REFERENCES
- Babu J. R., Pandit J. K. Effects of aging on the dissolution stability of glibenclamide b-cyclodextrin complex. Drug Develop. Ind. Pharm. 1999; 25: 1215–1219
- http://www.anvisa.gov.br/legis/resol/2002/56002re.htm Brasil.Resolução – RE nº 560 de 2 de abril de 2002. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. Disponível em: 2002. Acesso em 15 de fevereiro de 2003.
- http://e-legis.bvs.br/leisref/public/showAct.php?mode=PRINT_VERSION&id=13227 Brasil.Resolução – RE nº 398 de 12 de novembro de 2004. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. 2004. Disponível em
- http://e-legis.bvs.br/leisref/public/showAct.php?id=18109&mode=PRINT_VERSION Brasil.Resolução – RE nº 1, de 29 de julho de 2005. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. 2005. Disponível em
- Carstensen J. T. Interactions of moisture with solids. Drug Stability: Principles And Practices. University of Wisconsin – Madison, Marcel Dekker, New York 1995; 281–303
- Florence A. T., Attwood D. Estabilidade de drogas. Princípios Físicos Químicos em Farmácia. Editora da Universia de São Paulo (EDUSP), São Paulo 2003; 155–218, (in Portuguese)
- Grimm W. Storage conditions for stability testing-long term testing and stress tests. Drugs Made in Germany 1986; 29: 39–47
- Grimm W. Storage conditions for stability testing in the EC, Japan and USA; The most important market for drug products. Drug Develop. Ind. Pharm. 1993; 19(20)2795–2830
- Grimm W. Extension of the international conference on harmonization tripartite guideline for stability testing of new drug substances and products to countries of climatic zones III and IV. Drug Develop. Ind. Pharm. 1998; 24(4)313–325
- Haynes J. D. Worldwide virtual temperature for product stability testing. J. Pharm. Sci. 1971; 60(6)927–929
- Hogerzeil H. V., De Goeje M.J., Abu-Reid I.O. Stability of essential drugs in Sudan. Lancet 1991; 338: 754–755
- Hüttenrauch R. Physico-chemical changed from a molecular-galenical view point. Stability Testing of Drug Products, W. Grimm. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1987; 17–32
- IBGE. Atlas Do Censo Demográfico. IBGE, Brazil 2000
- ICHQ1F. Guidance for Industry. Stability Data Package for Registration Applications in Climatic Zones III and IV. 2004
- Kommanaboyina B., Rhodes C.T. Trends in stability testing, with emphasis on stability during distribution and storage. Drug Develop. Ind. Pharm. 1999; 25: 857–868
- Matthews R. B. Regulatory aspects of stability testing in Europe. Drug Develop. Ind. Pharm. 1999; 25: 831–856
- Nazerali H., Muchemwa T., Hogerzeil H. V. The quality and stability of essential drugs in tropical climates. Inland Stability Study Zimbabwe 1996, WHO/DAP/94.16.
- http://strategis.ic.gc.ca/epic/internet/inimr-ri.nsf/en/gr118345e.html Oliveira, J. (2003). Brazil: Market Overview of Drugs and Pharmaceuticals. US & Foreign Commercial Service and US Department of State.
- Palmeira Filho P. L., Pan S. S. K. Cadeia farmacêutica no Brasil: Avaliação preliminar e perspectivas. BNDES Setorial, Rio de Janeiro 2003; 18: 13–22, (in Portuguese).
- Pandit J. K., Tripathi M. K., Babu J. R. Effects of disintegrants on the dissolution stability of solid oral dosage forms. Pharmazie 1997; 52: 538–540
- Peixoto J. P., Oort A. H. Physics of Climate. New York, AIP Press 1992
- Risha P. G., Shewiyo D., Msami A., Masuki G., Vergote G., Vervaet C., Remon J.P. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop. Med. Int. Health 2002; 7: 701–707
- Risha P. G., Vervaet C., Vergote G., Van Bortel L., Remon J. P. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. Eur. J. Clinic. Pharmacol. 2003; 59: 135–141
- www.bndes.gov.br/conhecimento/setorial/get4is25.pdf Saab, W. G. L., & Ribeiro, R. M. (2001). Um panorama do varejo de farmácias e drogarias no Brasil, Área de Operações Industriais 2 (AO2). Gerência Setorial de Comércio e Serviço, 25, (in Portuguese). 5 p. Disponívem em
- Saville D. J. Influence of storage on in vitro release of ibuprofen from sugar coated tablets. Int. J. Pharm. 2001; 224: 39–49
- Stull R. B. An Introduction to Boundary Layer Meteorology. Kluwer Academic Publishers, Amsterdam 1988
- Taylor J. Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products. Pharma. J. 2001; 267(28)128–131
- Young W. R. Accelerated temperature pharmaceutical product stability determinations. Drug Develop. Ind. Pharm. 1990; 16(4)551–569
- http://www.who.int/druginformation/vol18num2_2004/DI18-2.pdf WHO (2004a). Aspects of the quality assurance. WHO Drug Information 18(2), 113–116
- http://www.who.int/medicines/services/expertcommittees/pharmprep/QAS05_146Stabilitywithcomments.pdf WHO (2004b). Stability studies in a global environment. Geneva meeting. Working document QAS/05.146 with comments, 10 pp